New Zealand markets close in 19 minutes

ABBV Aug 2024 125.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.80000.0000 (0.00%)
As of 03:17PM EDT. Market open.
Full screen
Previous close0.8000
Open0.8000
Bid0.0000
Ask0.0000
Strike125.00
Expiry date2024-08-16
Day's range0.8000 - 0.8000
Contract rangeN/A
Volume2
Open interestN/A
  • Zacks

    AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

    AbbVie (ABBV) closed at $164.25 in the latest trading session, marking a +1.05% move from the prior day.

  • Reuters

    UPDATE 1-US FDA warns of harmful reactions to fake Botox injections

    The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that unsafe counterfeit versions of AbbVie's Botox were given to consumers for cosmetic purposes in multiple states. The U.S. Centers for Disease Control and Prevention (CDC) and the FDA are investigating reports of harmful reactions among people who received injections of counterfeit Botox. As of April 12, a total of 19 people from nine states had reported harmful reactions after receiving Botox injections from unlicensed or untrained individuals, or in non-healthcare settings, such as homes and spas, according to the CDC.

  • Zacks

    AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

    Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.